Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives

Use of combined oral contraceptives (OC) is associated with a significant risk of thrombosis. The mechanisms of this effect are not clearly defined. Tissue factor pathway inhibitor (TFPI) is a circulating anti‐coagulant that inhibits the earliest steps in activation of the extrinsic coagulation path...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of hematology Vol. 60; no. 3; pp. 175 - 180
Main Authors Harris, Geoffrey M., Stendt, Caroline L., Vollenhoven, Beverley J., Gan, T. Eng, Tipping, Peter G.
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.03.1999
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…